Fundings, 2009 (Nov/Dec only)

2017   2016   2015   2014   2013   2012   2011   2010   2009

December

  • Hepa Wash GmbH has raised $5.74 million (€ 3.8 million in a Series A financing round (liver assist device)
  • Neostim, Inc., has raised $1 million according to a regulatory filing (neuromodulation of nervous system-mediated disorders)
  • Advanced Cell Technology, has raised $2.77 million in financing from debt and options, according to a regulatory (human embryonic stem cell technology)
  • Echo Therapeutics, Inc., has raised $563K in a funding round according to a regulatory filing (ultrasound-based transdermal drug delivery)
  • Apnex Medical, Inc., has raised $14 million in its second round of funding (implantable device for treatment of obstructive sleep apnea)
  • Nautilus Neurosciences, Inc., has raised $13.08 million according to a regulatory filing.
  • TransMedics, Inc., has raised $3.57 million according to a regulatory filing (preservation system for organ transplant)
  • Medisse BV has received an undisclosed sum in a financing round from BioGeneration Ventures (biomaterials for resorbable implants in a range of clinical applications)
  • TiGenix NV has raised $11.33 million (€ 7.7 million) in a private placement (products for tissue repair and regeneration)
  • Monterey Devices, Inc., has raised $2.55 million according to a regulatory filing (drug delivery systems)
  • Ophthotech Corp. raises $30 million in Series B financing (biopharmaceutical treatments for wet and dry age-related macular degeneration)
  • AxioMed Spine Corp. has raised $6.4 million toward a projected total $18.5 million Series C round (spinal disc replacements)
  • Hoana Medical, Inc., has raised $10.2 million in an oversubscribed Series C financing (system for non-contact measurement of vital signs)
  • ImplicitCare LLC, has raised $1.48 million according to a regulatory filing (surgical suture system)
  • Asthmatix Inc. has raised $27 million in a Series C financing (medical device for outpatient treatment of asthma)
  • Taris Biomedical, Inc., has raised $5 million according to a regulatory filing (device for localized drug delivery)
  • Cardo Medical, Inc., has raised $6.2 million according to a regulatory filing (reconstructive products for orthopedic surgery)
  • California Stem Cell, Inc., has raised an undisclosed sum in a second round of financing (stem cell treatments for spinal cord injuries)
  • EnzySurge Ltd. has raised $2.5 million in a round of financing (products for wound management)
  • Cambridge Heart has raised $1.85 million in a financing round according to a regulatory filing (noninvasive cardiac diagnostics)
  • Syncro Medical Innovations, Inc., has raised $500K in a financing round according to a regulatory financing (enteral feeding tube)
  • CleveX, Inc., has raised $696K in a financing round according to a regulatory filing (skin biopsy, closure and repair)
  • Bioject Medical Technologies, Inc., has raised $1.2 million in a financing round according to a regulatory filing (needlefree injection of liquid medications)
  • HistoSonics, Inc., has raised $5 million in financing according to a regulatory filing (ultrasound based tissue ablation for BPH, others)
  • Coapt Systems, Inc., has raised $3.72 million in a funding rounding including debt, securities, warrants and rights (soft tissue fixation in aesthetic applications)

November

  • Activaero GmbH has raised $16 million in a Series A financing (pulmonary drug delivery device)
  • SpinalMotion, Inc., has raised $27.4 million in a Series C financing (therapeutic devices for treatment of chronic pain)
  • On-Q-ity has raised $21 million in a Series A round (cancer cell detection and testing platform)
  • Novaray Medical, Inc., has raised $5.9 million according to a regulatory filing (digital x-ray technology for cardiac catheterization and other applications)
  • Facet Solutions, Inc., has raised $3.6 million according to a regulatory filing (surgical devices for spine disorders)
  • Light Sciences Oncology has raised $11.8 million in financing via warrants, in addition to $23 million in credit (drug/device combination for killing malignant tumors)
  • SpectraScience has raised $4.3 million in financing through a private placement (fluorescence based technology for cancer detection)
  • Eso-Technologies, Inc., has raised $1 million in funding from angel investors (esophageal monitoring device to replace peripheral artery catheter)
  • Promethera Biosciences, Inc., has raised € 5.3 million ($7.94 million) in a Series A funding (stem cell therapy)
  • Checkpoint Surgical, LLC, has raised $1.1 million in a round of financing (handheld disposable nerve stimulator)
  • Hamilton Thorne, Inc., has raised $2.1 million in a private placement (stem cell therapy research)
  • Ortho Kinematics has raised $3.5 million in a funding round (spine motion analysis diagnostics)
  • Fate Therapeutics, Inc., has raised $30 million in a Series B financing (induced pluripotent stem cell technology platform)
  • Cardo Medical, Inc., has raised $6.2 million in a private placement (reconstructive orthopedic and spinal surgery products)
  • NuOrtho Surgical, Inc., has raised $1 million in a second round of funding (tissue preservation for orthopedic procedures)
  • Entellus Medical, Inc., has raised $30 million in a series D funding (less invasive treatment of sinusits)
  • Onset Medical has raised $1.2 million of a planned $12.1 million funding round (percutaneous access products)
  • Trireme Medical, Inc., has raised nearly $7.1 million of a planned $14 million funding round (delivering prostheses to luminal bifurcations)
  • Corindus, Inc., has raised $5.3 million of a planned $10 million Series C funding (robotic systems to assist with guidewires for placement of vascular stents)
  • Calibra Medical, Inc., has raised $1.4 million in a funding round according to a regulatory filing (insulin delivery device)
  • Echo Therapeutics, Inc., has raised $3 million in a funding round according to a regulatory filing (ultrasound-based transdermal drug delivery)
  • Humacyte, Inc., has raised $7 million in debt financing according to a regulatory filing (tissue scaffolding technology)
  • Cardiola Ltd. has added $4 million to its Series E financing, bringing the round to $6.3 million (muscular counter pulsation for treatment of heart failure)
  • Svelte Medical Systems, Inc., has raised $6 million toward a planned $9 million funding round according to a regulatory filing (developing a non-thrombogenic, non-inflammatory drug-eluting stent)
  • Entrigue Surgical, Inc., has raised $3.2 million according to a regulatory filing (biomaterials and instruments for head and neck surgery)
  • Spine View, Inc., has raised $6.3 million according to a regulatory filing (technologies focused on improving spinal decompression and fusion)
  • EndoGastric Solutions, Inc., has raised $21.5 million on a Series E financing (endoluminal procedures for upper gastric conditions)
  • Apnex Medical, Inc., has raised $14.05 million of a planned $19.05 million round of funding (sleep apnea implantable treatment device)
  • BaroSense, Inc., has received and undisclosed amount in funding from iNovia Capital in a Series B round (minimally invasive treatment of obesity)

2017   2016   2015   2014   2013   2012   2011   2010   2009